Larvol Delta - AcelRx-Pharmaceuticals-Announces-Publication-of-Clinical-Data-Showing-Reduced-Hospital-Length-of-Stay-and-Reduced-Opioid-Utilization-with-Use-of-Sublingual-Sufentanil-in-Total-Joint-Replacement-Surgery

Dsuvia (sufentanil sublingual) - AcelRx

https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-publication-of-clinical-data-showing-reduced-hospital-length-of-stay-and-reduced-opioid-utilization-with-use-of-sublingual-sufentanil-in-total-joint-replacement-surgery-301444913.html

Dec 15, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next